02 Apr [MCE] Breaking the Chains, Immune Checkpoint Inhibitory Antibodies Lead a New Chapter in Immunotherapy!
Tumor Immunotherapy During tumor development, immunotherapy inhibits highly expressed immune checkpoint molecules to restore T-cell recognition, thereby clearing or slowing tumor progression[1]. Immune Checkpoint Inhibitory Antibody Programmed cell death 1 (PD-1) is the T-cell immune checkpoint molecule of greatest interest. PD-1 or PD-L1 inhibitory antibodies upregulate T-cell activation and activate...